This story was initially revealed by Knowable Journal.
At age 49, Jan Janisch-Hanzlik’s a number of sclerosis was destroying her freedom to dwell the life she needed. She gave up her energetic nursing job for a desk function. Frequent falls made her afraid to hold her grandchildren. She needed to transfer to an even bigger home to make room for the wheelchair she feared she may find yourself needing full-time.
Even the very best obtainable treatment wasn’t enhancing Janisch-Hanzlik’s signs, and he or she nervous they’d solely worsen. So when she discovered a couple of trial of CAR T cell remedy on the College of Nebraska Medical Middle in Omaha, near town of Blair the place she lives, she phoned the clinic each different month till they had been able to enroll her as the primary affected person.
Initially designed to focus on and wipe out most cancers by reprogramming the affected person’s immune cells, CAR T is now being provided to sufferers in lots of of medical trials for autoimmune circumstances like a number of sclerosis, lupus, Graves’ illness, vasculitis, and lots of others. The hope is that CAR T can duplicate the success it has demonstrated in a variety of blood cancers by searching down and eliminating cells that concentrate on the self in autoimmune illnesses. This is able to basically reset the physique’s defenses to a state just like the one which existed earlier than the illness took maintain.
However together with CAR T’s promise come dangers, questions and challenges. There’s uncertainty about how properly it can work for autoimmunity and the way lengthy any advantages may final, in addition to what long-term unintended effects may come up. Janisch-Hanzlik knew this when she sat all the way down to obtain the experimental remedy on June 9, 2025; she felt a mixture of hope and worry understanding that she can be spending the subsequent week being monitored for unintended effects together with harmful irritation.
Along with her medical experience and need to pioneer a brand new remedy, Janisch-Hanzlik’s two younger grandchildren helped encourage her pursuit of a remedy with identified dangers and unsure advantages. As a result of a number of sclerosis has a genetic element, Janisch-Hanzlik knew that they’ve an elevated likelihood of going by the identical wrestle she has. “I might need to have the ability to say I did every part that I probably might to stop them, or anybody else, from having one thing like this,” she says.
From Most cancers to Autoimmunity
The primary CAR T most cancers remedy was authorized by the Meals and Drug Administration in 2017 for an aggressive type of leukemia. Since then, the highly effective and intensive remedy has resulted in long-term remission for a lot of most cancers sufferers.
The essential premise of CAR T is to activate the facility of key immune cells referred to as T cells. T cells usually acknowledge different cells which have been contaminated by a virus or bacterium, or are in any other case irregular, and both destroy them or recruit different elements of the immune system to take action.
In CAR T for most cancers, scientists engineer these T cells to particularly hunt and destroy malignant cells. The expertise received its begin when most cancers researchers discovered easy methods to take out a affected person’s personal T cells, insert DNA directions for a “chimeric antigen receptor,” or CAR, and put them again into the particular person’s circulation. The CAR, which sits on the T cell’s floor and latches on to a particular molecular companion on the floor of cancerous cells, prompts the T cell to assault.
As we speak, CAR T cells are mostly programmed to assault B cells, one other key immune participant. B cells are usually accountable for making antibodies, however in sure blood cancers, they proliferate uncontrolled. By giving T cells a CAR that acknowledges one among a few molecules distinctive to the B cell floor, the cells are reprogrammed to seek out and eradicate these cancerous cells.
B cells are also the central drawback in lots of autoimmune circumstances: They mistakenly make antibodies towards regular tissues as a substitute of towards invading pathogens. In order CAR T started to succeed towards B cell cancers, it didn’t take lengthy for medical doctors to cause that CAR T remedy may also have the ability to wipe out unhealthy B cells in folks with autoimmunity.
A German workforce pioneered autoimmune CAR T in a lady with lupus, reporting constructive outcomes in 2021. Since then, that workforce and others have labored to translate the oncology success of CAR T to sort out a broad spectrum of autoimmune illnesses.
“I feel it’s a recreation changer,” says Amanda Piquet, an autoimmune neurologist on the College of Colorado Anschutz in Aurora. Piquet is evaluating CAR T remedy for a uncommon and poorly understood autoimmune situation referred to as stiff particular person syndrome, with signs together with muscle stiffness and painful spasms. There isn’t any FDA-approved remedy. When she heard about an organization referred to as Kyverna that was testing CAR T cell remedy within the syndrome, she thought it was “an ideal alternative.”
The research she led, which reported preliminary outcomes in December 2025, examined a single dose of CAR T in 26 folks. Earlier than the remedy, many members struggled with a gradual, mechanical gait, and 12 used assistive gadgets akin to walkers and canes. Most sufferers had been capable of stroll sooner by 16 weeks post-treatment, and eight now not wanted their assistive gadgets for brief distances. In April, the corporate reported that each one 26 sufferers, as of their final follow-up appointment 4 to 12 months out from the remedy, had been now not utilizing another immunotherapies.
Dangers and Uncertainties
Regardless of such putting outcomes, reprogramming the immune system is not any easy matter. In early remedy of most cancers sufferers, CAR T cells produced life-threatening unintended effects, as outlined in a 2026 article within the Annual Evaluation of Medication. As CAR T cells assault their targets, the related irritation could cause signs like excessive fevers and low blood stress. If that irritation reaches the mind, it may trigger extra issues akin to confusion and drowsiness.
Thankfully, physicians now have a decade’s value of expertise recognizing and treating these issues. “They’re actually reversible and don’t trigger long-term harm more often than not,” says Emily Littlejohn, a rheumatologist on the Cleveland Clinic.
Physicians and sufferers additionally should take care of decreased immunity as each a facet impact of the remedy and its desired final result. In CAR T remedy, medical doctors sometimes use highly effective chemotherapy medicine to briefly cut back the physique’s immune cell inhabitants to make room for the brand new, engineered cells, leaving sufferers briefly immunosuppressed. And if the remedy works, it can decimate B cell populations. Sufferers will be susceptible to infections for as much as a yr after remedy, says Littlejohn.
These results are manageable with preventive antibiotics, antivirals, and vaccines. Sufferers additionally retain antibodies that their B cells made earlier than the remedy, which give residual safety for a number of months. And for causes that aren’t but absolutely understood, CAR T appears to depart older B cells, which give immune reminiscence of previous infections, intact in some instances. One research discovered that autoimmune sufferers handled with CAR T nonetheless made antibodies for illnesses they’d been beforehand vaccinated towards, like hen pox and measles. These are indicators that the remedy didn’t utterly return the immune system to its manufacturing unit settings.
When evaluating CAR T threat, it’s necessary to contemplate that many current remedies for autoimmune illness additionally suppress the immune system for so long as an individual takes them, consultants be aware.
However there are different doable CAR T dangers for autoimmune sufferers. In February, FDA officers revealed a paper endorsing CAR T’s potential in autoimmunity however warning of “unpredictable long-term toxicity.” CAR T remedy for most cancers, the authors famous, has been linked to various long-term points akin to Parkinson’s illness. There have additionally been instances the place the bioengineered cells themselves turned malignant, inflicting new, T cell-based cancers.
Inflicting a secondary most cancers could also be a suitable threat when treating a life-threatening most cancers, however in all probability not for autoimmunity, says Matt Lunning, medical director for gene and mobile remedy at Nebraska Medication in Omaha. The best way to stability the chance between the impacts of an autoimmune illness, which may vary broadly in severity, and the difficult-to-quantify threat of future unintended effects or cancers stays a significant open query.
Researchers are already engaged on second- and third-generation variations of CAR T that they count on to be safer for each most cancers and autoimmunity. For instance, James Howard, a neuromuscular neurologist on the College of North Carolina at Chapel Hill, is testing a expertise from an organization referred to as Cartesian Therapeutics that encodes the CAR utilizing molecules of mRNA, the short-lived genetic messenger utilized in Covid-19 vaccines, as a substitute of long-lasting DNA. The CAR T cells ought to wipe out B cells for under so long as the mRNA persists, then lose their B cell-targeting skills. With no likelihood for genetically modified T cells to hold round long-term, there must be no most cancers threat.
One other plus of Cartesian’s strategy: Physicians infuse these T cells in ample numbers that they don’t want to breed within the affected person’s physique, which Howard thinks reduces threat for irritation. In a latest trial, 15 folks with autoimmune illnesses obtained the Cartesian CAR T remedy; two-thirds noticed their signs enhance and none suffered long-term severe unintended effects.
Treating CAR T Sticker Shock
Past unintended effects, the opposite main problem going through CAR T remedy is its price ticket, which reaches lots of of 1000’s of {dollars} together with hospital stays, cell engineering, and different bills.
The remedy would doubtless be cheaper, and easier, if scientists might eradicate the necessity for customized engineering of every affected person’s personal cells and as a substitute use donor cells, or if they may lower out the step of engineering and rising the cells in a laboratory. Lunning says he’s eyeing up-and-coming procedures that may modify an individual’s T cells inside their very own physique as a substitute of doing the genetic engineering in a lab.
Researchers are even farther together with a model of CAR T that makes use of wholesome donors as a supply of T cells. These might then be utilized by many sufferers in an “off-the-shelf” strategy. It’s a way that has its personal challenges, due to the immune mismatch between donor and affected person cells that may cause them to assault one another. This drawback will be overcome with extra genetic modifications to the donated T cells that forestall recipient and donor programs from recognizing one another as international, says Bing Du, an immunologist at East China Regular College in Shanghai who’s amongst many researchers engaged on this strategy. Du estimates a lab might make CAR T cells for greater than 1,000 sufferers from a single donor’s blood cells, at vital value financial savings.
This sort of off-the-shelf CAR T remedy is what Janisch-Hanzlik of Nebraska obtained, underneath Lunning’s care, in 2025. The research organizers at TG Therapeutics count on to finish their analysis in early 2029.
Janisch-Hanzlik ended up crusing by the follow-up with out unintended effects. A few months after the infusion, she was watching TV when she observed she now not wanted particular glasses to appropriate double imaginative and prescient. She began forgetting to carry her cane when shifting about her home or going grocery buying; she didn’t want it. Now, almost a yr because the remedy, she not often falls and now not requires a every day, three-hour nap. She lately loved a visit to the Grand Canyon and appears ahead to spending extra time along with her grandchildren.
She does nonetheless have signs, together with weak point in her proper leg, numbness and tingling in her ft, and issue discovering the fitting phrase when talking. She asks her medical doctors in the event that they assume she’s going to get higher, keep the identical or worsen once more.
“I’ve been instructed so many occasions, ‘We don’t know, you’re the primary. We’re simply going to have to attend and see,’” she says. “I undoubtedly am grateful for each day I’ve.”
This text initially appeared in Knowable Journal, an impartial journalistic endeavor from Annual Evaluations. Join the publication.